| | | | | | | | With the pandemic finally in our rearview, the U.S. has what many industry insiders see as a golden opportunity to candidly assess pharma’s reshoring progress — and create a more formal plan for supply chain resilience. In this two-part series, we assess pharma’s reshoring progress, including efforts to establish a reshoring list, the importance of ongoing government support and the role of advanced technologies. |
|
|
|
| |
| | |
|
|
| | | | | The facility will host 55 full-time employees, and is expected to be completed by the third quarter of 2025. |
|
|
| To ensure access, Gilead will provide lenacapavir at no profit until the generic manufacturers can fully demand. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
